Insider trades
Robert Hershberg, Director of Recursion Pharmaceuticals RXRX, has filed 0 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $367.5K. The latest trade was on 06/17.
Robert Hershberg
Director
- First filing
- 23/02/03
- Trades
- 32 trades
- Buys / sales
- 0 / 5
- 12-month net buying
- −$367.5K
- Last trade
- 06/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 25/12/10 | 25/12/12 | 22,968 sh | $16.00 | $367,488 | −33.0% | |
| Open-market sale | 25/03/12 | 25/03/12 | 53,000 sh | $7.59 | $402,270 | −43.2% | |
| Open-market sale | 25/02/04–25/02/11 | 25/02/12 | 26,535 sh2 trades | $1.83avg. | $48,604.02 | −2.4% | |
| Open-market sale | 24/02/08 | 24/02/12 | 11,597 sh | $14.93 | $173,143.21 | −1.2% |
